Tauroursodeoxycholate + Traditional Chinese Medicine for Diabetic Macular Edema

This trial explores new treatments for diabetic macular edema, a condition that can blur vision in some people with diabetes. It tests two treatments: Tauroursodeoxycholate (TUDCA, a bile acid supplement) and a traditional Chinese medicine formula, a mix of herbs known to support eye and liver health. The goal is to determine if these treatments can reduce inflammation and improve eye health without the discomfort and cost of current therapies. Individuals with diabetic retinopathy, an eye condition related to diabetes, who experience blurred vision might be suitable candidates for this trial. As a Phase 2 trial, the research focuses on evaluating the treatment's effectiveness in an initial, smaller group of participants.

Yes, you may need to stop taking certain medications. The trial excludes participants currently taking anti-inflammatory medications, COX-2 inhibitors, and certain statins. It's best to discuss your specific medications with the trial team.

In earlier studies, Tauroursodeoxycholate (TUDCA) has shown potential for improving eye health. Research suggests that TUDCA can protect eye cells from damage caused by high sugar levels, common in diabetes, and might help with issues like diabetic macular edema. Tests in animals and cells have noted only a few side effects, indicating it is generally well-tolerated.

Traditional Chinese Medicine (TCM), specifically a formula called mQJDHW, has also been studied for its eye health benefits. Research shows that this formula can improve eye health and reduce inflammation. Although detailed safety information is limited, TCM has been used for many years with reports of few side effects, suggesting it might be safe to use.

Researchers are excited about these treatments for diabetic macular edema because they offer novel approaches compared to standard medications like anti-VEGF injections and corticosteroids. Tauroursodeoxycholate (TUDCA) is unique as it is a bile acid supplement that targets neuroinflammation and neurodegeneration, potentially reducing retinopathy. Meanwhile, the Traditional Chinese Medicine formula mQJDHW combines natural ingredients known for enhancing ocular health and providing neuroprotection. These treatments could offer alternative or complementary options to current therapies by addressing underlying oxidative stress and inflammation differently.

Research has shown that Tauroursodeoxycholate (TUDCA), which participants in this trial may receive, benefits eye health. Studies have found that TUDCA can protect retinal cells, slow damage, and reduce cell death, which is crucial for managing diabetic macular edema. Early results suggest it helps maintain the retina's structure and may reduce retinal degeneration.